Mount Sinai Heart is a leader in this emerging treatment, and we were one of the first hospitals in the New York metropolitan area to offer Mitraclip Rx. Abbott ltd makes Mitraclip device. It is a FDA approved product. Its recommended for patients who are having moderate to severe mitral regurgitation who are having persistent symptoms in spite of maximal medical therapy (with prohibitive risk for open heart surgery , if MR is due to primary valve problem)

You will be treated by an experienced multidisciplinary team that includes interventional cardiologists, cardiac surgeons, an echocardiographer, anesthesia, intensivists, nurse practitioners, clinical nurses, research coordinators, and other support staff.